Swiss Re (VTX:SREN) received a CHF 107 target price from equities research analysts at HSBC in a research note issued on Friday. The firm presently has a “buy” rating on the stock. HSBC’s price objective would indicate a potential upside of 13.28% from the stock’s previous close.
A number of other research firms have also recently commented on SREN. UBS Group set a CHF 86 target price on Swiss Re and gave the company a “sell” rating in a research note on Thursday, November 30th. Goldman Sachs Group set a CHF 95 target price on Swiss Re and gave the company a “neutral” rating in a research note on Monday, November 6th. Morgan Stanley set a CHF 108 target price on Swiss Re and gave the company a “buy” rating in a research note on Monday, November 6th. Credit Suisse Group set a CHF 96 target price on Swiss Re and gave the company a “neutral” rating in a research note on Wednesday. Finally, DZ Bank reissued a “buy” rating on shares of Swiss Re in a research note on Tuesday. Three analysts have rated the stock with a sell rating, nine have assigned a hold rating and nine have assigned a buy rating to the company’s stock. Swiss Re presently has a consensus rating of “Hold” and an average target price of CHF 96.84.
Swiss Re (VTX:SREN) traded down CHF 0.14 on Friday, reaching CHF 94.46. The company had a trading volume of 2,250,000 shares, compared to its average volume of 1,390,000. The company has a market capitalization of $32,780.00 and a PE ratio of 12.08. Swiss Re has a 1-year low of CHF 81.65 and a 1-year high of CHF 95.30.
About Swiss Re
Swiss Re AG is a wholesale provider of reinsurance, insurance and other insurance-based forms of risk transfer. The Company operates in four segments: Property&Casualty Reinsurance, Life&Health Reinsurance, Corporate Solutions and Life Capital. Its Reinsurance Unit provides premiums and fee income through Property&Casualty and Life&Health segments.
Receive News & Ratings for Swiss Re Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Swiss Re and related companies with MarketBeat.com's FREE daily email newsletter.